摘要
背景:1999年鉴定的磷酸二酯酶10(PDE 10)家族主要表达于大脑,尤其是纹状体、中等棘神经元、伏隔核和嗅结节。PDE 10抑制剂(PDE 10-IS)是一门概念合理的药物化学学科,在治疗精神疾病和神经退行性疾病方面具有潜在的应用价值。 目的:在文献综述的基础上,综述PDE 10作为精神病学和神经退行性药物发现的合理靶点的细胞和分子生物学研究进展。本文从药物化学的角度,从茶碱和咖啡因类似物、罂粟碱和二甲氧基邻苯二酚型PDE 10-is、TP-10、MP-10、MP-10/罂粟碱/喹唑啉系列抑制剂入手,对PDE 10-进行了分类。作者根据PDE10A在精神分裂症、帕金森病、亨廷顿病和阿尔茨海默氏病动物模型中的作用,对PDE10A作为精神科和神经退行性疾病的治疗策略进行了近期的研究。本文还介绍了PDE 10的药理数据,认为PDE 10是治疗认知缺陷、肥胖和抑郁的可能药物。此外,根据临床试验的结果,总结了PDE 10-是药物发现的当前策略。作者还介绍了PDE 10配合物与新型抑制剂的晶体结构的最新研究。
关键词: 磷酸二酯酶10,PDE 10抑制,中枢神经系统药物开发,抗精神病药物,精神分裂症,帕金森病,认知。
Current Medicinal Chemistry
Title:Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery
Volume: 25 Issue: 29
关键词: 磷酸二酯酶10,PDE 10抑制,中枢神经系统药物开发,抗精神病药物,精神分裂症,帕金森病,认知。
摘要: Background: The phosphodiesterase 10 (PDE10) family, identified in 1999, is mainly expressed in the brain, particularly in the striatum, within the medium spiny neurons, nucleus accumbens, and olfactory tubercle. Inhibitors of PDE10 (PDE10-Is) are a conceptually rational subject for medicinal chemistry with potential use in the treatment of psychiatric and neurodegenerative diseases.
Objective: This review is based on peer-reviewed published articles, and summarizes the cellular and molecular biology of PDE10 as a rational target for psychiatric and neurodegenerative drug discovery. Here, we present the classification of PDE10-Is from a medicinal chemistry point of view across a wide range of different, drug-like chemotypes starting from theophylline and caffeine analogs, papaverine and dimethoxy catechol type PDE10-Is, TP-10, MP-10, MP-10/papaverine/quinazoline series inhibitors, and ending with the newest inhibitors obtained from fragment-based lead discovery (FBLD). The authors have collated recent research on inhibition of PDE10A as a promising therapeutic strategy for psychiatric and neurodegenerative diseases, based on its efficacy in animal models of schizophrenia, Parkinson’s, Huntington’s, and Alzheimer’s diseases. This review also presents pharmacological data on PDE10-Is as possible therapeutics for the treatment of cognitive deficits, obesity and depression. Moreover, it summarizes the current strategies for PDE10-Is drug discovery based on the results of clinical trials. The authors also present the latest studies on crystal structures of PDE10 complexes with novel inhibitors.
Export Options
About this article
Cite this article as:
Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery, Current Medicinal Chemistry 2018; 25 (29) . https://dx.doi.org/10.2174/0929867325666180309110629
DOI https://dx.doi.org/10.2174/0929867325666180309110629 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Development of 14-Alkoxy Substituted Morphinans as Potent and Safer Opioid Analgesics
Current Medicinal Chemistry Aging of the Innate Immune System: An Update
Current Immunology Reviews (Discontinued) Aspartic Proteases in Drug Discovery
Current Pharmaceutical Design Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews The Ultra High Risk Approach to Define Psychosis Risk
Current Pharmaceutical Design An Overview of Drug Screening Using Primary and Embryonic Stem Cells
Combinatorial Chemistry & High Throughput Screening Psychiatric/Psychosocial Rehabilitation (PSR) in Relation to Social and Leisure Environments: Friends and Recreation
Current Psychiatry Reviews Parkinsons Disease Dementia
Current Psychiatry Reviews Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Conduction Disorders in the Setting of Acute STEMI
Current Cardiology Reviews Evaluation of Treatment Tolerability, Satisfaction and Laboratory Parameters in HIV+ Patients Switching from Ritonavir Capsule to Tablet Formulation§
Current HIV Research Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task
Current Pharmaceutical Design Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
Current Gene Therapy Oxidation Inhibits Iron-Induced Blood Coagulation
Current Drug Targets Recent Progress in BINOL Mediated Asymmetric Reactions
Mini-Reviews in Organic Chemistry Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis
CNS & Neurological Disorders - Drug Targets